Flow cytometry is the most powerful tool for analysis of cellular populations, but there is still is a wealth of untapped potential for additional applications. BennuBio Inc. has greatly expanded the power of flow cytometry by developing instruments that can use the flow cytometry paradigm to analyze samples regardless of particle size or sample volume. Moreover, these instruments simplify workflows to save time and money. Our gentle approach retains sample viability and morphology while analyzing at considerably faster rates. Thereby, improving diagnostics, decreasing time to markets and accelerating fundamental health science research. Our initial technology has been funded by a series of NIH grants and investment by Tramway Venture Partners, Cottonwood Technology Fund, and Sun Mountain Capital.